# A Study to Assess the Safety of ARGX-124 in Healthy Volunteers

> **NCT07377396** · PHASE1 · RECRUITING · sponsor: **argenx** · enrollment: 104 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** ARGX-124
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07377396
- **Lead sponsor:** argenx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-26
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377396, "A Study to Assess the Safety of ARGX-124 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07377396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*